CY1119193T1 - Διασπειρομενο δισκιο μισοπροστολης - Google Patents

Διασπειρομενο δισκιο μισοπροστολης

Info

Publication number
CY1119193T1
CY1119193T1 CY20171100848T CY171100848T CY1119193T1 CY 1119193 T1 CY1119193 T1 CY 1119193T1 CY 20171100848 T CY20171100848 T CY 20171100848T CY 171100848 T CY171100848 T CY 171100848T CY 1119193 T1 CY1119193 T1 CY 1119193T1
Authority
CY
Cyprus
Prior art keywords
dispropriate
disc
half ship
misoprostol
pharmaceutically acceptable
Prior art date
Application number
CY20171100848T
Other languages
English (en)
Inventor
Sekar Selvaraj
Baskar Elumalai
Malaiarasan Arunachalam
Prabhakaran Venugopal
Original Assignee
Azanta Danmark A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Azanta Danmark A/S filed Critical Azanta Danmark A/S
Publication of CY1119193T1 publication Critical patent/CY1119193T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ένα στερεό φαρμακευτικό σκεύασμα περιλαμβάνον μισοπροστόλη ή ένα φαρμακευτικώς αποδεκτό άλας αυτής. Συγκεκριμένα, η εφεύρεση αναφέρεται σε ένα διασπειρόμενο δισκίο περιλαμβάνον μισοπροστόλη ή ένα φαρμακευτικώς αποδεκτό άλας αυτής.
CY20171100848T 2014-07-11 2017-08-08 Διασπειρομενο δισκιο μισοπροστολης CY1119193T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14176821.8A EP2965750B1 (en) 2014-07-11 2014-07-11 Misoprostol dispersible tablet

Publications (1)

Publication Number Publication Date
CY1119193T1 true CY1119193T1 (el) 2018-02-14

Family

ID=51167770

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100848T CY1119193T1 (el) 2014-07-11 2017-08-08 Διασπειρομενο δισκιο μισοπροστολης

Country Status (12)

Country Link
EP (2) EP3238715A1 (el)
CY (1) CY1119193T1 (el)
DK (1) DK2965750T3 (el)
ES (1) ES2645481T3 (el)
HR (1) HRP20171220T1 (el)
HU (1) HUE033619T2 (el)
LT (1) LT2965750T (el)
MA (1) MA39549B1 (el)
PL (1) PL2965750T3 (el)
PT (1) PT2965750T (el)
RS (1) RS56468B1 (el)
SI (1) SI2965750T1 (el)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125450A1 (en) 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol
CA2610465A1 (en) 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US8148560B2 (en) 2005-09-23 2012-04-03 Teva Women's Health, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
WO2009154810A2 (en) * 2008-02-25 2009-12-23 Dr. Reddy's Laboratories Ltd. Delivery systems for multiple active agents
CN102697746B (zh) * 2012-06-11 2014-03-19 广州朗圣药业有限公司 一种快速融变的米索前列醇阴道用组合物及其制备方法和应用
MX2015001007A (es) 2012-07-26 2015-04-09 Ferring Bv Composicion de misoprostol.
CN102872024B (zh) * 2012-09-28 2015-06-17 天津市聚星康华医药科技有限公司 口腔内使用的米索前列醇药物组合物
CN103340837B (zh) * 2013-07-08 2018-04-27 天津市聚星康华医药科技有限公司 一种米索前列醇阴道泡腾片及其制备方法

Also Published As

Publication number Publication date
EP2965750A1 (en) 2016-01-13
EP3238715A1 (en) 2017-11-01
DK2965750T3 (en) 2017-10-16
PT2965750T (pt) 2017-10-03
MA39549B1 (fr) 2019-04-30
EP2965750B1 (en) 2017-08-02
ES2645481T3 (es) 2017-12-05
RS56468B1 (sr) 2018-01-31
HUE033619T2 (en) 2017-12-28
SI2965750T1 (sl) 2017-11-30
LT2965750T (lt) 2017-09-25
MA39549A1 (fr) 2017-12-29
HRP20171220T1 (hr) 2017-11-03
PL2965750T3 (pl) 2018-01-31

Similar Documents

Publication Publication Date Title
NL301286I2 (nl) Danicopan, of een farmaceutisch aanvaardbaar zout ervan
NL301224I2 (nl) Combinatie van foslevodopa en foscarbidopa, elk desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
BR112016023628A2 (pt) composições farmacêuticas.
PH12016501763A1 (en) Multispecific antibodies
NL301260I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
CY1124425T1 (el) Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
DK3236935T3 (da) Farmaceutisk doseringsform til anvendelse på slimhinder
FR3023988B3 (fr) .
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3199161T3 (da) Farmaceutisk præparat
EA202092926A3 (ru) Лиофилизированные составы, содержащие фактор ix
BR112017022439A2 (pt) composições para higiene bucal.
TR201901228T4 (tr) Vortioksetin piroglutamat.
ITUB20152693A1 (it) Protesi osteointegrata alveoloimplantare.
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
BR112017002672A2 (pt) composição para barreira do sabor.
DK3174533T3 (da) Oral desintegrerende tablet
DK2915526T3 (da) Farmaceutiske sammensætninger, der omfatter anagrelid
EA201700060A1 (ru) Терапевтическое средство для кератоконъюнктивальных расстройств
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
DK3089740T3 (da) Farmaceutisk sammensætning